EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 19 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,147,000 | -0.9% | 220,000 | 0.0% | 0.15% | -35.6% |
| Q1 2022 | $2,167,000 | +612.8% | 220,000 | 0.0% | 0.23% | +339.6% |
| Q4 2021 | $304,000 | -85.4% | 220,000 | +4.8% | 0.05% | -83.2% |
| Q3 2021 | $2,087,000 | -0.5% | 210,000 | 0.0% | 0.32% | +1.0% |
| Q2 2021 | $2,098,000 | – | 210,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exos Asset Management LLC | 50,000 | $502,000 | 0.39% |
| Arena Capital Advisors, LLC- CA | 300,000 | $3,020,000 | 0.30% |
| MMCAP International Inc. SPC | 250,000 | $2,516,000 | 0.25% |
| PERISCOPE CAPITAL INC. | 350,000 | $3,523,000 | 0.14% |
| Kepos Capital LP | 175,000 | $1,761,000 | 0.11% |
| Ghisallo Capital Management LLC | 150,000 | $1,508,000 | 0.10% |
| Shaolin Capital Management LLC | 200,000 | $2,013,000 | 0.08% |
| Atalaya Capital Management LP | 40,000 | $402,000 | 0.08% |
| Radcliffe Capital Management, L.P. | 200,000 | $2,013,000 | 0.08% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 57,789 | $581,000 | 0.07% |